TY - JOUR
T1 - Effectiveness of sotalol treatment in symptomatic Brugada syndrome
AU - Glatter, Kathryn A.
AU - Wang, Qing
AU - Keating, Mark
AU - Chen, Shenghan
AU - Chiamvimonvat, Nipavan
AU - Scheinman, Melvin M.
PY - 2004/5/15
Y1 - 2004/5/15
N2 - We describe a 53-year-old man with recurrent syncopal events and a malignant family history who was treated for 13 years with sotalol drug therapy with no further occurrence of Brugada syndrome symptoms. Genetic testing revealed that he carried a Brugada syndrome sodium channel SCN5A mutation (4189delT). This finding suggests that sotalol may be of therapeutic benefit in such patients.
AB - We describe a 53-year-old man with recurrent syncopal events and a malignant family history who was treated for 13 years with sotalol drug therapy with no further occurrence of Brugada syndrome symptoms. Genetic testing revealed that he carried a Brugada syndrome sodium channel SCN5A mutation (4189delT). This finding suggests that sotalol may be of therapeutic benefit in such patients.
UR - http://www.scopus.com/inward/record.url?scp=2342458202&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2342458202&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2004.02.023
DO - 10.1016/j.amjcard.2004.02.023
M3 - Article
C2 - 15135718
AN - SCOPUS:2342458202
VL - 93
SP - 1320
EP - 1322
JO - American Journal of Cardiology
JF - American Journal of Cardiology
SN - 0002-9149
IS - 10
ER -